Owner Scorecard


← All companies ← VCTR Manual VECO → ← ULS Life Sciences Tools & Services WAT →

VCYT, Veracyte Inc.

We serve global markets with two complementary models.

Insights from these tests help patients avoid unnecessary procedures and interventions and accelerate time to appropriate treatment, thereby improving outcomes for patients across our global markets.

Our Novel Approach — the Veracyte Diagnostics Platform We have established a novel approach to drive the successful launch and adoption of our high-performing tests, which we refer to as the Veracyte Diagnostics Platform.

Latest annual: FY2025 10-K
VCYT · Veracyte Inc.
I

The business

What it sells, where the money comes from, the kind of company it is.

Revenue · FY2025
$517M
+16.0% YoY · 35% 5-yr CAGR
Vital signs · TTM, with 5-yr average
Revenue $562M 5-yr avg $368M
Operating margin 18.8% 5-yr avg −12.0%
ROIC 10% 5-yr avg −2%
Owner-earnings margin 30% 5-yr avg 6%
Free cash flow margin 30% 5-yr avg 6%

Next report By 11/8 · the 10-Q for the quarter ended late September · due within 40 days of period end · has filed ~38 days after · the wire records it on arrival

The business in brief

read the 10-K →

What this business is and what moves its needle, from its own SEC filings.

What moves the needle
Operating margin has reached 11% at its best but run negative through the cycle (median −24%) on a 64% gross margin — so the question is which reading is truer: whether the median was pulled below zero by one-off charges, by the cycle, or by spending it is still growing into, and whether it settles back at a profit. Stock-based pay runs about 9.0% of sales, a real and recurring claim on owners that the GAAP margin understates. Read this kind of business on volume, payer mix and reimbursement. On its own account, the filing leans hardest on pricing power & competition, set against the numbers in what the filing emphasizes, below.
Is it a good business?
Return on capital has rarely cleared the cost of capital (median −11%, above 15% in 0 of 10 years). Owner earnings, the cash-based check, have been thin too. This is price-taker territory, where the balance sheet and the cycle matter more than any multiple; the rest is in the 10-K.

Every line is arithmetic on the company's filings, shown in full in the sections below.

II

The record

Ten years of arithmetic, read across the cycle.

The record, 2016–2025

realized figures from each filing · older years to the left
2016’162017’172018’182019’192020’202021’212022’222023’232024’242025’25TTMTTMJun 2026
Income statement
$65M$72M$92M$120M$117M$220M$297M$361M$446M$517M$562MRevenueRevenue
$40M$44M$59M$84M$176M$230M$298M$363M$526MGross profitGross prof.
61%61%64%70%59%64%67%70%94%Gross marginGross mgn
80%77%71%69%76%83%58%52%46%41%36%SG&A / revenueSG&A/rev
24%19%16%12%15%14%14%16%16%14%17%R&D / revenueR&D/rev
($29M)($27M)($22M)($15M)($35M)($82M)($41M)($86M)$16M$58M$106MOperating incomeOp. inc.
−44.3%−36.9%−24.2%−12.6%−30.1%−37.3%−13.9%−23.8%3.6%11.2%18.8%Operating marginOp. mgn
($31M)($31M)($23M)($13M)($35M)($82M)($36M)($77M)$26M$68MPretax incomePretax
($31M)($31M)($23M)($13M)($35M)($76M)($37M)($74M)$24M$66M$114MNet incomeNet inc.
6%3%1%Effective tax rateTax rate
Cash flow & returns
($28M)($24M)($14M)($3M)($10M)($32M)$8M$44M$75M$136M$178MOperating cash flowOp. cash
$4M$4M$4M$4M$8M$20M$26M$27M$23M$21M$21MDepreciation & amortizationD&A
($7M)($3M)($400K)($5M)$4M$2M($9M)$58M($9M)$5M($5M)Working capital & otherWC & other
$4M$2M$2M$3M$3M$5M$9M$10M$11M$10M$12MCapexCapex
6.5%2.4%2.0%2.3%2.4%2.4%2.9%2.8%2.5%1.9%2.2%Capex / revenueCapex/rev
($32M)($26M)($15M)($6M)($13M)($37M)($1M)$34M$64M$127M$166MOwner earningsOwner earn.
−49.5%−35.7%−16.7%−5.0%−10.7%−16.9%−0.3%9.5%14.3%24.5%29.5%Owner earnings marginOE mgn
($32M)($26M)($15M)($6M)($13M)($37M)($1M)$34M$64M$127M$166MFree cash flowFCF
−49.5%−35.7%−16.7%−5.0%−10.7%−16.9%−0.3%9.5%14.3%24.5%29.5%Free cash flow marginFCF mgn
$0$0$0$0$0$574M$0$0$0$0$0AcquisitionsAcquis.
($4M)($1M)($2M)($43M)($4M)($739M)($29M)$15M($56M)($9M)Investing cash flowInv. cash
$52M($218K)$59M$127M$204M$596M$3M$3M$5M($4M)Financing cash flowFin. cash
$0$0($2M)($592K)$163K($424K)$719KExchange-rate effectFX
$20M($25M)$44M$81M$190M($176M)($19M)$62M$23M$124MChange in cashΔ cash
-90%-74%-65%-15%-38%-7%-4%-8%2%6%10%ROICROIC
-53%-83%-29%-5%-8%-7%-3%-7%2%5%8%Return on equityROE
−53%−83%−29%−5%−8%−7%−3%−7%2%5%8%Retained to equityRetained/eq
Balance sheet
$59M$34M$78M$159M$349M$173M$154M$216M$239M$363M$350MCash & investmentsCash+inv
$9M$13M$13M$19M$18M$41M$44M$40M$47M$45M$54MReceivablesReceiv.
$3M$5M$3M$7M$5M$11M$14M$16M$22M$21M$21MInventoryInvent.
$2M$4M$3M$2M$3M$12M$12M$13M$9M$5M$8MAccounts payablePayables
$10M$14M$14M$24M$20M$40M$46M$44M$60M$61M$67MOperating working capitalOper. WC
$74M$54M$97M$188M$376M$243M$249M$286M$372M$488M$575MCurrent assetsCur. assets
$12M$12M$13M$17M$17M$64M$63M$61M$79M$60M$63MCurrent liabilitiesCur. liab.
6.4×4.5×7.4×10.7×22.4×3.8×4.0×4.7×4.7×8.1×9.2×Current ratioCurr. ratio
$11M$10M$9M$9M$9M$15M$18M$21M$23M$22MNet PP&ENet PP&E
$1M$1M$1M$3M$3M$708M$696M$703M$746M$767M$767MGoodwillGoodwill
$101M$79M$121M$275M$457M$1.2B$1.2B$1.1B$1.3B$1.4B$1.5BTotal assetsAssets
$25M$25M$25M$694K$810K$1M$0Total debtDebt
($34M)($9M)($53M)($159M)($349M)($172M)($154M)Net debt / (cash)Net debt
-10.4×-5.4×-11.3×-22.3×-154.5×470.1×Interest coverageInt. cov.
$41M$41M$41M$36M$36M$91M$81M$71M$124M$96MTotal liabilitiesTotal liab.
$60M$37M$80M$239M$421M$1.1B$1.1B$1.0B$1.2B$1.3B$1.4BShareholders’ equityEquity
9.8%9.2%6.5%8.1%11.1%10.3%9.0%9.2%8.1%8.4%8.6%Stock comp / revenueSBC/rev
Per share
28.8M33.9M37.0M46.1M53.2M67.9M71.5M72.6M78.2M80.6M81.8MShares out (diluted)Shares
$2.26$2.12$2.49$2.61$2.21$3.23$4.14$4.97$5.70$6.42$6.87Revenue / shareRev/sh
$-1.09$-0.91$-0.62$-0.27$-0.66$-1.11$-0.51$-1.02$0.31$0.82$1.40EPS (diluted)EPS
$-1.12$-0.76$-0.42$-0.13$-0.24$-0.54$-0.01$0.47$0.82$1.57$2.03Owner earnings / shareOE/sh
$-1.12$-0.76$-0.42$-0.13$-0.24$-0.54$-0.01$0.47$0.82$1.57$2.03Free cash flow / shareFCF/sh
$0.15$0.05$0.05$0.06$0.05$0.08$0.12$0.14$0.14$0.12$0.15Cap. spending / shareCapex/sh
$2.07$1.10$2.15$5.19$7.91$16.15$15.03$14.37$15.05$16.25$16.98Book value / shareBVPS
Per-share growththe realized rate an owner's share compounded
9-yr5-yr
Revenue / share+12.3%/yr+23.8%/yr
Capital spending / share−2.1%/yr+17.6%/yr
Book value / share+25.8%/yr+15.5%/yr

The year, in the company's words

the filing →

Verbatim from the 10-K's management discussion. Each sentence is shown only because its subject, direction, and stated figures check out against the filed numbers on this page. The words are the company's; the arithmetic is the record's.

  • Testing+17.7%
    “Testing revenue increased by $74.2 million, or 18%, driven by a $66.7 million increase in Decipher revenue and a $13.7 million increase in Afirma revenue.”
    ✓ figure matches the filed record
  • Biopharmaceutical And Other-26.5%
    “Biopharmaceutical and other revenue decreased by $3.5 million for the year ended December 31, 2025 compared to 2024, due to the decrease in the business conducted in France given the restructuring proceedings affecting Veracyte SAS in August 2025.”
    ✓ figure matches the filed record

Where the cash went

ReinvestBuybacksDividendsAcquisitionsRetainedBeyond op. cash

Each year's outlays against its operating cash: the mix, and how it drifts. The hatched cap is spending beyond that year's operating cash — financed from the balance sheet or borrowing, not operations.

FY2022FY2025

Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.

In fiscal 2025 the business turned $66M of profit into $127M of owner earnings: more cash than the profit line showed, after the non-cash charges and the capital it put back in.

Reported net income$66M
Owner earnings$127M · 24% of revenue
FY2025FY2024FY2023FY2022FY2021
Reported net income$66M$24M($74M)($37M)($76M)
Depreciation & amortizationnon-cash charge added back+$21M+$23M+$27M+$26M+$20M
Stock-based compensationreal costnon-cash, but a real cost+$44M+$36M+$33M+$27M+$23M
Working capital & othertiming of cash in and out, other non-cash items+$5M−$9M+$58M−$9M+$2M
Cash from operations$136M$75M$44M$8M($32M)
Capital expenditurecash put back in to keep running and to grow−$10M−$11M−$10M−$9M−$5M
Owner earnings$127M$64M$34M($1M)($37M)
Owner-earnings marginowner earnings ÷ revenue24%14%9%0%-17%

Owner earnings is the cash an owner could pull out without starving the business: operating cash less the capital it must spend to hold its position . The cash-flow statement also adds stock comp back as non-cash, but it is a real cost paid in shares; counted as the expense it is (less $44M), owner earnings is nearer $83M.

Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.

III

Quality & stewardship

Returns, the balance sheet, capital allocation, and pay.

Owner’s Scorecard

FY2025 10-K · source on SEC EDGAR →

Will it survive?

  • No meaningful interest burden
    Little or no interest expense reported
    What this means

    Little or no interest expense reported, the business isn't leaning on lenders to operate.

  • Net cash, debt-free
    Cash $363M − debt $0
    What this means

    Cash and short-term investments exceed every dollar of debt by $363M, on net the company owes nothing, and can act from strength when others can't. Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.

  • Not enough data
    What this means

    The filing data didn't include the inputs for this check.

Is it a good business?

  • Below average through the cycle
    10-yr median, range -90%–6%; 6% latest = NOPAT $56M ÷ invested capital $947M
    Industry peers: median -19%
    What this means

    The rate the business earns on the money tied up in it, Buffett's north star, because over time a stock tracks the ROIC beneath it. Above ~15% sustained hints at a moat; a return below the cost of capital (~8%) erodes value as a business grows rather than building it — the test Buffett weighs most. The headline is the median of the last 10 years (it ran 6% most recently), so one peak or trough year doesn't set the verdict. Asset-light businesses (R&D expensed, little capital) read artificially high, pair this with Owner Earnings.

  • High, recently turned positive
    latest $127M = operating cash $136M − maintenance capex $10M; positive each of the last 3 years, after an earlier loss stretch (10-yr median -8%)
    Industry peers: median -31%
    What this means

    What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's 24% of revenue this year, a -8% median across 10 years. Treating stock comp as the real expense it is (less $44M of SBC) leaves $83M.

  • Cash-backed
    Cash from ops $136M ÷ net income $66M
    What this means

    How much of reported profit showed up as operating cash. Above 1× is reassuring; well below suggests earnings lean on accruals. One year is noisy, growth and working-capital swings distort it, and this is operating cash, not free cash. Watch the multi-year trend.

How is the cash used?

  • Not enough data
    What this means

    The filing data didn't include the inputs for this check.

  • Investing or harvesting? 0.45×
    Harvesting
    Capex $10M ÷ depreciation & amortization as filed $21M
    What this means

    Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.

The promise and the pay packet

  • Modest selling cost
    Selling and marketing $100M ÷ revenue $517M
    What this means

    Sales and marketing as a share of revenue, kept apart from administrative overhead because it answers a different question: how much a business must spend to win the next customer. A company whose product pulls customers in spends little here and keeps the difference; one that must buy its growth is running to stand still, and the spending has to keep rising for revenue to keep rising. Read it beside the growth rate, not alone.

  • Is the buyback buying ownership, or mopping up? 8.4%
    The count is rising
    Stock compensation $44M (fiscal 2025), 8.4% of revenue · no repurchases · diluted shares +12.6% since 2022
    What this means

    Stock handed to employees is a real cost paid in the owner's own currency: it is charged against profit, but the shares it creates are permanent. Many companies repurchase stock at the same time, which looks like a return of capital and often is not — if the count barely moves, the cash merely cancelled the pay packet and bought the owner nothing. The three states worth telling apart are a count genuinely shrinking, a count standing still despite large repurchases, and a count rising because the issuance was never offset at all.

Graham’s defensive tests · 2 of 4 met

Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.

  • Adequate size Miss
    Revenue ≥ $2B · $517M
    What this means

    Big enough to weather a storm. Graham's 1972 floor was ~$100M of sales (≈ $700M today); we use a $2B revenue line as a conservative modern stand-in.

  • Strong liquidity Pass
    Current ratio ≥ 2× · 8.15×
    What this means

    Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.

  • Conservative debt Pass
    Debt ≤ working capital · $0 vs $428M WC
    What this means

    Graham's rule that borrowings not exceed net current assets. Capital-heavy and buyback-heavy firms routinely fail it, read it next to interest coverage, not alone.

  • Earnings stability Miss
    A profit every year (10-yr record) · 8 loss years
    What this means

    Graham wanted earnings in each of the past ten years, the stability a defensive owner leans on.

  • Dividend record
    Uninterrupted dividends · no dividend line tagged in the data
    What this means

    An unbroken dividend was Graham's mark of durability. This record carries no dividends-paid line in any year — common for partnerships, whose distributions file under tags the chain doesn't read — so the criterion is withheld rather than judged on silence.

  • Earnings growth
    Earnings +33% over the record ·
    What this means

    Earnings were negative early in the record, a growth rate isn't meaningful.

  • Moderate price
    P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price
    What this means

    Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are $0.07/share (latest year $0.83), the averaged base the calculator's gate runs on, and book value is $16.29/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.

Durability & moat, 2016–2025

Whether the record’s returns held, and what the capital reinvested earned.

  • Profitable years 2 of 10
    What this means

    Lost money in 8 year(s), look at what happened there before trusting the average.

  • Return on capital ≥ 15% 0 of 7 yrs
    What this means

    A moat shows up as a high return on invested capital that holds year after year, not one good vintage.

  • Operating margin −35% → −3% (3-yr avg ends)
    What this means

    Through the cycle the operating margin widened — about −35% early to −3% lately, median −24% — pricing power intact or improving.

  • Reinvestment, incremental ROIC 4%
    What this means

    Reinvested capital came back at only a modest incremental return — near the cost of capital, where extra growth adds little per dollar. The record shows whether it is a soft stretch or a thinning moat.

  • Worst year 2016 · −44.3% op. margin
    What this means

    Operations went underwater in 2016, understand why before trusting the good years.

All figures as filed; the source filing is linked above.

Current Position

as of the latest quarter, Jun 30, 2026

Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.

Current assets$575M
  • Cash & short-term investments$350M
  • Receivables$54M
  • Inventory$21M
  • Other current assets$150M
Current liabilities$63M
  • Accounts payable$8M
  • Other current liabilities$55M
Current ratio9.16×all current assets ÷ what's due · Graham looked for 2×
Quick ratio8.83×stricter: inventory excluded
Cash ratio5.58×strictest: cash alone against what's due
Working capital$512Mthe cushion left after near-term bills
Revenue, latest quarter vs. a year ago+15.5%the freshest read on whether the business is still growing
Current ratio, recent quarters5.1× → 9.2×
Deeper floors
Tangible book value$539Mequity stripped of goodwill & intangibles
Net current asset value$477MGraham's net-net: current assets less all liabilities
Debt incl. operating leases$40M$40M of it operating leases
Deferred revenue$597Kcustomer cash collected before delivery; operating float

From the company's latest filing.

How the cash was used, 2016–2025

Over the record, the business generated $153M of operating cash; how management split it reads as a cash builder, a large share of cash simply built up on the balance sheet.

  • Reinvested$58M · 38%
  • Retained (debt / cash)$95M · 62%
  • Source of fundingOperating cash

    Operating cash covered reinvestment and returns; over the span cash and short-term investments rose $291M.

  • Net change in share count183.6%

    The diluted count rose from 29M to 82M: issuance (stock pay, deals) outran any buybacks, so owners were diluted on net.

  • Dividend record

    No dividend line was reported in the filing data over the span; the record here neither confirms nor rules out a payout.

Buybacks are gross of stock issued to staff; the share-count line above is the net of that, the figure that decides whether owners gained. The average price paid blends a year of purchases (and any accelerated repurchase), so it is close, not exact. The record of where the cash went and on what terms.

Acquisitions & goodwill

from the balance sheet & the 10-year cash-flow record

Goodwill grows only when a company acquires and falls only when it concedes it overpaid. The size of that bet, the cash put into buying rather than building, and how much has already been written off.

Goodwill & intangibles$856M61% of all assets; the premium carried on the balance sheet for businesses acquired
Against book equity59%goodwill is this share of book equity; the rest is the company’s own retained and paid-in capital
Cash spent acquiring$576Mover 12 years since fiscal 2014 buying other businesses, against $58M of capital spent building over the 10-year record

None written down over the record; the goodwill is still carried at full cost. That is the deals holding their value on the books so far; whether they keep doing so is the test an owner watches, since the write-down, when it comes, is the admission the price was too high.

Beside that spending sits $97M of cumulative amortization of acquired intangibles charged against earnings since fiscal 2014 — the purchase price of past deals, expensed over time.

Goodwill, acquired intangibles and equity from the latest balance sheet; acquisition spend and amortization summed across the company's full tagged history, write-downs across the 10-year record, from the company's own filings.

Management, ownership & pay

read the proxy →

From the proxy: how much of the business the people running it own, and how they are paid, beside what the business earned for its owners in the same years.

Fiscal yearChief executivePay, as filed“Actually paid”Owner earnings
2021Bonnie Anderson$4.5M$2.9M($37M)
2021Marc Stapley$5.7M$5.7M($37M)
2022Marc Stapley$4.9M$1.6M($1M)
2023Marc Stapley$7.2M$9.6M$34M
2024Marc Stapley$6.8M$14.9M$64M
2025Marc Stapley$7.4M$9.6M$127M

Both pay figures are the company’s own, from the pay-versus-performance table its proxy statement files. “As filed” is the Summary Compensation Table total: salary, bonus, and equity awards at their value on the day of grant. “Actually paid” is the SEC’s prescribed recalculation, which re-marks those equity awards to what they became as they vested; it can swing far above or below the filed figure in either direction, and negative years occur. Owner earnings are the whole business's, from the record above, for the same fiscal years.

  • Insider ownership<1%

    The stake all directors and executive officers hold together, per the 2026 proxy: skin in the game, the first thing Munger reads.

  • Stock-based compensation$44M

    The slice of the business handed to employees in shares in fiscal 2025, 8.4% of revenue, equal to 75.5% of operating profit. Buffett's oldest accounting fight: this is compensation, compensation is an expense, real whether or not the headline earnings admit it. One trap: the cash-flow statement adds SBC back, so the operating cash, and the owner earnings drawn from it, are flattered by exactly this amount; counted as the cost it is, what an owner keeps is lower.

What an owner would ask, FY2025

read the 10-K →
  • Which reported numbers are a judgment call?
    Management names Revenue recognition, Income taxes, Inventory, Acquisitions as critical estimates

    each rests partly on management's judgment; the filing's note sets out the assumptionsverify →

The questions the record and the charts do not answer on their own; each carries the figure and the place to look.

Peers, Life Sciences Tools & Services

The same industry, side by side on owner economics. Each column names the period it is read over, and a median resting on fewer than three years carries that count beside it; the group median at the foot is the line to read each figure against.

CompanyRevenuelatest FY, USDGross marginmedian over the recordOp. marginmedian over the recordROICmedian over the recordOwner earn. marginmedian over the record
GHGuardant Health Inc.$982M61%3y-101.3%-30%-62%
CAICaris Life Sciences Inc.$812M-62.4%-62%
VCYTVeracyte Inc.$517M64%-24.0%-11%-8%
CDNACareDx Inc.$380M61%4y-19.8%-26%-30%3y
CSTLCastle Biosciences Inc.$344M81%-14.6%-18%-0%
FLGTFulgent Genetics Inc.$323M55%-10.0%-3%7%
BLLNBillionToOne Inc.$305M53%-30.9%-31%
GRALGRAIL Inc. Common Stock$147M-382.0%1y-47%2y-204%1y
Group median61%-27.4%-22%-30%
IV

The price

What a price has to assume.

What the price implies

reverse-DCF

Type today's close and see the owner-earnings growth you'd have to believe to justify it, beside what Veracyte Inc. has delivered.

$
Base

The assumptions

9.0% = the 4.71% 10-year Treasury (Aug 18, 2026) + 4.29 points of equity premium. The rate you require is yours to set.

Enter a price above to run it.

Implied by the price
Owner-earnings growth · since FY2023+92%/yr
Owner-earnings yield
P/E (3-yr earnings ’23–’25)
P/B
Graham’s price gate

Graham capped the multiple at 15×; Buffett and Munger let that rule go: a wonderful business can deserve 50× if the thesis holds. The gate marks the bargain-hunter's floor.

Against a high-grade bond: Graham’s yardstick bond yield%

Prefilled with the 10-year Treasury (4.71%, as of Aug 18, 2026). Edit it for today’s exact figure, or a AAA corporate yield.

Graham measured a stock against the bond you could own instead, the heart of his margin of safety. Enter a price above to weigh the owner-earnings yield against this bond.

Free cash flow $166M on 80M shares outstanding, per the 10-Q cover, as of 2026-07-27; net cash $350M. The base is the latest year by default; Normalize values it on the through-cycle median owner-earnings margin (to avoid paying on a peak year). Net of stock comp treats option pay as the expense it is. Capex ($12M) runs well above depreciation ($21M), so this is a build-out; Steady-state swaps total capex for maintenance (≈ depreciation), lifting the base to about $169M, the cash it would throw off if it stopped expanding. The dials set the multiple a growth belief justifies; the price, and every dollar on this page, is yours.

Cite: Owner Scorecard, "Veracyte Inc. (VCYT), the owner's record," https://ownerscorecard.com/c/VCYT, data as of 2026-08-17.

Manual order: ← VCTR its page in the Manual VECO →

Industry order: ← ULS the Life Sciences Tools & Services chapter WAT →